- 全部删除
- 您的购物车当前为空
Vanucizumab是一种双特异性的人源化单克隆抗体,同事抑制VEGF-A和Angiopoietin-2(Ang-2)的受体相互作用,具有抗血管生成和抗癌作用,可用于治疗晚期实体瘤。
Vanucizumab是一种双特异性的人源化单克隆抗体,同事抑制VEGF-A和Angiopoietin-2(Ang-2)的受体相互作用,具有抗血管生成和抗癌作用,可用于治疗晚期实体瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,880 | In stock | |
5 mg | ¥ 6,570 | In stock | |
10 mg | ¥ 8,860 | In stock |
Vanucizumab 相关产品
产品描述 | Vanucizumab is a bispecific humanised monoclonal antibody that simultaneously inhibits the receptor interactions of VEGF-A and Angiopoietin-2 (Ang-2), exhibiting anti-angiogenic and anti-cancer effects, and can be used for the treatment of advanced solid tumours. |
别名 | 伐努赛珠单抗, RO5520985, RO 5520985, Anti-Human VEGFA Recombinant Antibody |
CAS No. | 1448221-05-3 |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容